TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Friday reported a loss of $1.3 million in its fiscal fourth quarter.
The Toronto-based company said it had a loss of 4 cents per share.
The extended-release drug developer posted revenue of $232,500 in the period. Its adjusted revenue was $233,000.
For the year, the company reported that its loss narrowed to $8.1 million, or 37 cents per share. Revenue was reported as $3.5 million.
In the final minutes of trading on Friday, the company's shares hit 12 cents. A year ago, they were trading at 31 cents.